The Calmer Co International Limited (ASX:CCO)

Market Cap	9.18M -44.5%
Revenue (ttm)	8.10M +12.5%
Net Income	-3.37M
EPS	-0.00
Shares Out	3.06B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,385,858
Average Volume	2,282,435
Open	0.0040
Previous Close	0.0030
Day's Range	0.0030 - 0.0040
52-Week Range	0.0020 - 0.0060
Beta	0.47
RSI	46.86
Earnings Date	n/a

About ASX:CCO

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. In addition, it sells its products through retailers and online. The company was formerly known as Fiji ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CCO

Financial Performance

In fiscal year 2025, ASX:CCO's revenue was 8.03 million, an increase of 88.48% compared to the previous year's 4.26 million. Losses were -3.99 million, 7.13% more than in 2024.